Author(s)

Innocent Kashongwe Murhula^1,2, Fina Mawete², Lay Ofali², Michel Kaswa², Francois Lepira Bompeka¹, Jean Marie Kayembe Ntumba^1,2, Zacharie Kashongwe Munogolo^1,2

¹School of Medicine, Kinshasa University Hospital, Kinshasa, Democratic Republic of Congo.
²National Tuberculosis Program, Kinshasa, Democratic Republic of Congo.

The Democratic Republic of Congo is one of the countries with a high preva-lence of multidrug-resistant tuberculosis (MDR-TB) in Africa and worldwide. This study aims to describe the trends and level of screening since 2013. This is a retrospective descriptive study based on quarterly reports from the provinces. The number of cases, past histories, age, sex and HIV Co-infection was identi-fied. It emerges that the number of cases increases significantly but does not reach the forecasts yet (912 cases of MDR/RR and XDR diagnosed in 2017 out of 3948 cases expected with a gap of 77%). Patients with a history of TB pre-dominate (63.5% in 2017); but the proportion of patients with no history of TB increases (36.5% in 2017). This suggests high rates among contacts. Women (37.8%) and children under 15 (2.7%) are less represented. TB/HIV Co-infection is 12% as for sensitive cases. Efforts still need to be made to improve screening.

MDR-RR TB, Trends Screening, DRC

Murhula, I. , Mawete, F. , Ofali, L. , Kaswa, M. , Bompeka, F. , Ntumba, J. and Munogolo, Z. (2019) Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017. Journal of Tuberculosis Research, 7, 212-219. doi: 10.4236/jtr.2019.74020.